James E. Pedicano

Phase I study in advanced cancer patients of a diversified prime-and-boost vaccination protocol using recombinant vaccinia virus and recombinant nonreplicating avipox virus to elicit anti-carcinoembryonic antigen immune responses.

E. Gehan, J. Marshall, J. Schlom, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I study in cancer patients of a replication-defective avipox recombinant vaccine that expresses human carcinoembryonic antigen.

J. Marshall, J. Schlom, E. Richmond, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I S tudy i n C ancer P atients o f a R eplication-Defe ctive Avipox R ecombinant V accine T hat E xpresses H uman Carcinoembryonic A ntigen

J. Marshall, J. Schlom, E. Richmond, 1999 .